https://www.selleckchem.com/products/bb-94.html
Grade 3 uveitis due to RBT occurred in three participants; three in Arm C had RBT Cmax 250ng/mL. Proportions with week 48 HIV-1 RNA 400 copies/mL were 58%, 67%, and 61% and week 8 sputum conversion were 88%, 82%, and 70%, respectively, in Arms A, B, and C. Double-dose LPV/r+RIF and LPV/r+RBT 150mg/day had acceptable safety, PK and TB outcomes; viral suppression was suboptimal unrelated to PK. Faster RBT clearance and low Cmax in three participants on RBT+RAL requires further study. Double-dose LPV/r+RIF and LPV/r+RBT 150mg/day had
Like
Comment
Share
